title: Ixazomib-induced thrombotic microangiopathy.
authors.affiliation: Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Jennifer C
authors.identifier: http://orcid.org/0000-0003-2375-9530
authors.initials: JC
authors.lastname: Yui
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Angela
authors.initials: A
authors.lastname: Dispenzieri
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Nelson
authors.initials: N
authors.lastname: Leung
mesh_terms: D000368:Aged; D001896:Boron Compounds / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D005998:Glycine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D057049:Thrombotic Microangiopathies / Q000139:chemically induced*
chemical_list: D001896:Boron Compounds; C548400:ixazomib; D005998:Glycine